Business Wire

BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence

Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader ...
Morningstar

BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence

Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. BlueWind Medical, Ltd., a leader in implantable Tibial ...
MassDevice

BlueWind wins FDA nod for enhanced urinary incontinence wearable

The enhanced Revi wearable tibial neuromodulation device. [Image courtesy of BlueWind Medical] BlueWind Medical announced today that the FDA granted 510(k) clearance for its enhanced Revi implantable ...
urologytimes

FDA grants 510(k) clearance to enhanced Revi System for urgency urinary incontinence

The Revi System, an implantable tibial neuromodulation device, received FDA 510(k) clearance for its enhanced version, improving urgency urinary incontinence treatment. The OASIS trial confirmed the ...